Physician

Pavan K Anand, M.D.

According to 2025 Medicare claims, Pavan Anand, M.D. (NPI: 1437341187) practices internal medicine in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is PAVAN K ANAND MD PA (NPI: 1265404354; TIN: 650923321) and primary practice location at 34102-5631. Anand is affiliated with the Advanced Doctors ACO, LLC (ACO ID: A4794), participating under the MSSP model.

Anand's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,157 traditional Medicare patients, billed 31,433 HCPCS/CPT codes, and received $1,361,713 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 15,626 prescription claims across 1,002 beneficiaries totaling $2,895,858 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 45 claims. Open Payments data shows 41 records totaling $1,223. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,140,587 to $1,361,713. Similarly, Part D prescription costs have risen steadily, from $1,502,750 to $2,895,858. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $39,212 to $9,247.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,417	49,440	$1,140,587
2016	1,380	43,087	$985,067
2017	1,395	39,097	$964,712
2018	1,386	45,215	$965,991
2019	1,370	44,356	$1,182,918
2020	1,321	32,886	$1,129,380
2021	1,324	39,719	$1,475,765
2022	1,307	29,375	$1,501,183
2023	1,226	22,997	$1,370,048
2024	1,157	31,433	$1,361,713

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,018	14,817	$1,502,750
2016	1,034	14,855	$1,461,828
2017	1,058	15,411	$1,399,067
2018	1,064	16,057	$1,609,268
2019	1,077	16,705	$1,735,430
2020	1,079	16,555	$1,826,753
2021	1,056	15,347	$1,796,318
2022	1,065	15,727	$1,991,529
2023	1,009	14,889	$2,706,402
2024	1,002	15,626	$2,895,858

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	82	577	$33,837
2016	71	527	$21,603
2017	17	275	$7,847
2018	18	306	$7,712
2019	34	259	$7,965
2020	23	160	$5,184
2021	21	176	$7,322
2022	N/R	95	$7,385
2023	N/R	55	$6,648
2024	11	45	$8,880

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,082	4,008	$96
99497	Advance care planning, first 30 minutes	894	894	$81
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	936	2,985	$47
G0442	Annual alcohol misuse screening, 5 to 15 minutes	909	909	$19
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	1,057	4,825	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	931	30,208	$1,078,490
Eliquis	Apixaban	242	17,474	$331,143
Jardiance	Empagliflozin	131	10,050	$188,921
Repatha Sureclick	Evolocumab	134	8,118	$154,577
Trulicity	Dulaglutide	104	3,574	$116,389

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	17	$8,470
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	11	28	$411

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	41	$1,223	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pavan K. Anand, M.D.?

Tedicare shows public-source Medicare data for Pavan K. Anand, M.D. (NPI 1437341187), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pavan K. Anand, M.D. have ACO affiliation data?

Pavan K. Anand, M.D. is shown with ACO affiliation data for Advanced Doctors ACO, LLC (MSSP, ACO ID A4794).

What billing organization is linked to Pavan K. Anand, M.D.?

Pavan K. Anand, M.D. is linked to PAVAN K ANAND MD PA (billing NPI 1265404354) in the available physician profile data.

Does Pavan K. Anand, M.D. have Open Payments data?

Pavan K. Anand, M.D. has 41 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.